Henrik Semb
- Molecular Biology top 1%
- Pluripotent Stem Cells Research 24
- Wnt/β-catenin signaling in development and cancer 12
- CRISPR and Genetic Engineering 11
- Metabolism, Diabetes, and Cancer 8
- Congenital heart defects research 6
- Cell Biology top 1%
-
- Diabetes Management and Research 7
- Surgery top 1%
- Pancreatic function and diabetes 36
- Oncology top 2%
-
- Diabetes and associated disorders 11
Henrik Semb
74 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 4.6k
- Cell Biology 816
- Endocrinology, Diabetes and Metabolism 796
- Surgery 2.1k
- Oncology 1.1k
Countries citing papers authored by Henrik Semb
This map shows the geographic impact of Henrik Semb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Semb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Semb more than expected).
Fields of papers citing papers by Henrik Semb
This network shows the impact of papers produced by Henrik Semb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Semb. The network helps show where Henrik Semb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Henrik Semb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2019 | 23 | |
| 7 | 2017 | 46 | |
| 8 | 2017 | 44 | |
| 9 | 2017 | 94 | |
| 10 | 2013 | 225 | |
| 11 | 2011 | 34 | |
| 12 | 2010 | 8 | |
| 13 | 2009 | 96 | |
| 14 | 2006 | 114 | |
| 15 | 2006 | 101 | |
| 16 | 2005 | 6 | |
| 17 | 2004 | 10 | |
| 18 | 2002 | 78 | |
| 19 | 1999 | 108 | |
| 20 | A causal role for E-cadherin in the transition from adenoma to carcinomabreakdown → | 1998 | 1170 |
About Henrik Semb
Henrik Semb is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Genetics and Cell Biology, having authored 76 papers that have together received 6.9k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (36 papers), Pluripotent Stem Cells Research (24 papers), Wnt/β-catenin signaling in development and cancer (12 papers), Diabetes and associated disorders (11 papers), CRISPR and Genetic Engineering (11 papers), Metabolism, Diabetes, and Cancer (8 papers), Diabetes Management and Research (7 papers) and Congenital heart defects research (6 papers). The work is most often cited by research in Molecular Biology (4.6k citations), Cell Biology (816 citations), Endocrinology, Diabetes and Metabolism (796 citations), Surgery (2.1k citations) and Oncology (1.1k citations). Henrik Semb has collaborated with scholars based in Sweden, Denmark and Germany. Frequent co-authors include Ulf Dahl, Gerhard Christofori, Anne‐Karina T. Perl, Petra Wilgenbus, Thomas Olivecrona, Anders Ståhlberg, Anders Sjödin, Joakim Håkansson, Mikael Kubista and Xiaojie Xian. Their work appears in journals such as Stem Cells, Development, PLoS ONE, Endocrinology and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.